Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: 0%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (718)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00991744	Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)	suspended	Phase 3	100	Nordic Society for Pediatric Hematology and OncologyOTHER	5	Oct 10, 2012	clinicaltrials

Data updated 22 days agoSource updated Oct 10, 2012source: clinicaltrials